Longitudinal study evaluates growth dynamics of brain arteriovenous malformations in HHT patients, suggesting minimal risk of rupture.
Abstract Purpose: The natural history of brain arteriovenous malformations (bAVMs) in Hereditary Hemorrhagic Telangiectasia (HHT) remains poorly understood and it has been suggested that they may have a benign course different from sporadic bAVMs. Here, we present a single-center longitudinal study evaluating the growth of bAVMs over time as assessed by serial MRIs. Methods: We performed a retrospective analysis of 44 patients with suspected bAVMs followed at an HHT Center of Excellence from 2014 to 2024. We excluded patients that did not have serial MRIs and/or poor-quality MRIs, and patients without radiographic bAVMs. Primary outcome was growth of bAVM as measured by largest dimension on T1 post-contrasted weighted sequences of serial MRIs. Secondary outcome was hemorrhage from bAVM rupture. Results: Twelve patients (3 male, 9 female) met our criteria. Average age at first MRI was 39.9 years (range 6 -65 years). Ten patients had micro-bAVMs and 3/10 of these patients had multiple micro-bAVMs. None of the micro-bAVMs showed any growth on serial MRIs. The other two patients in our study had bAVMs with niduses >1 cm and showed an average rate of growth of 1.61 mm/year. Ultimately, none of our patients had rupture of bAVMs over an average radiographic follow-up of 4.15 years and a total of 49.78 patient years. Conclusion: Our study suggests that bAVMs in HHT patients may have a benign natural history. We found no hemorrhages and noted minimal growth of bAVMs on serial MRIs. Our results suggest HHT patients with bAVMs may not warrant frequent surveillance imaging.
No takes yet. Share an insight, caveat, or question.
Li et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: